Oak Street Health downgraded to In Line from Outperform at Evercore ISI

Evercore ISI analyst Elizabeth Anderson downgraded Oak Street Health (OSH) to In Line from Outperform with a price target of $39, up from $25, after CVS Health (CVS) announced an agreement for its acquisition of Oak Street for $39 per share in cash.